Clinical Trial Update: Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^ [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a CRH1 receptor antagonist for anxious individuals with alcohol use disorder; the study is completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Anxiety Disorders

Drugs mentioned

• CRH1 receptor antagonist

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol-Related Disorders, Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2015-12-10